Amit Noheria is a Cardiology physician affiliated with University of Kansas. OpenAlex indexes 218 publications with 3,307 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4000 Cambridge St Ste G600
Kansas City, KS 66160
Telephone
913-588-9600Registry record last updated 8 Oct 2019.
Clinical trials
- ECG for Programming in CRT
Sponsor: Washington University School of Medicine
- Optimizing CRT With ECGI
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20259 payments
- Medtronic, Inc.Program year20253 payments
- BIOTRONIK INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.1%Beta blocker26.9%Metoprolol Succinate54%Metoprolol Tartrate21%Sotalol12%Carvedilol11%Propranolol Hcl Er3%Part D<11 patientsAntiarrhythmic19.9%Dofetilide29%Flecainide Acetate29%Amiodarone Hcl19%Mexiletine Hcl10%Propafenone Hcl6%Propafenone Hcl Er4%Multaq4%Part D<11 patients+ 10 more classes in this area
Blood & clotting
15.2%Factor Xa inhibitor12.8%Eliquis75%Xarelto25%Part D≥44 patientsP2Y12 inhibitor2.4%Clopidogrel100%Part D≥21 patientsMetabolism & gastrointestinal
8.7%SGLT2 inhibitor4.9%Jardiance81%Farxiga19%Part D<11 patientsProton pump inhibitor1.5%Pantoprazole Sodium100%Part D≥19 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Artificial Intelligence Interpretation of the Electrocardiogram: A State-of-the-Art Review
Current Cardiology Reports
2024 - UltraSound Axillary Vein Access (USAA): Learning curve and randomized comparison to traditional venous access for cardiac device implantation
Pacing and Clinical Electrophysiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Simari, MD
University of Kansas
Tara Lin, MD
University of Kansas
Diane Cibrik, MD
University of Kansas
Martin Mainster, MD
University of Kansas
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”